Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
Status:
Completed
Trial end date:
2017-08-16
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the efficacy of switching to tenofovir
disoproxil fumarate (TDF) compared to continuing stavudine or zidovudine in maintaining
virologic suppression in HIV-1 infected children.